Narcolepsy Type 2 / Orexin System - ME/CFS Cross-Disease Literature

1 Constantinescu 2011 β€” CSF Orexin-A Not Reduced in MS Fatigue (Null)

Full Citation:: Constantinescu CS, Niepel G, Patterson M, et al. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness. J Neurol Sci. 2011;307(1-2):127–131. (Constantinescu et al. 2011) DOI:: 10.1016/j.jns.2011.04.024 Study Design:: Case-control, CSF measurement Sample Size:: n=94 (34 MS + 60 controls) Key Findings::

- CSF orexin-A NOT reduced in MS patients compared to non-inflammatory controls
- No correlation between CSF orexin-A and fatigue scores (FSS) or sleepiness (ESS)
- CART (cocaine/amphetamine-regulated transcript) was elevated in MS
- Orexin-A slightly decreased in other inflammatory neurological diseases subgroup

Conclusion:: Null finding β€” orexin deficiency does not explain fatigue in MS despite significant neuroinflammation. Important counterexample: not all neuroinflammatory fatigue involves orexin suppression. Limitations:: MS-specific; does not rule out orexin involvement in ME/CFS; different cytokine profiles may produce different orexin effects. Certainty:: 0.65

2 Dauvilliers 2011 β€” High Pain Frequency in Narcolepsy with Cataplexy

Full Citation:: Dauvilliers Y, Bayard S, Shneerson JM, et al. High pain frequency in narcolepsy with cataplexy. Sleep Med. 2011;12(6):572–577. (Dauvilliers et al. 2011) DOI:: 10.1016/j.sleep.2011.01.010 Study Design:: Multicenter case-control Sample Size:: n=134 (67 NT1 + 67 matched controls) Key Findings::

- 32.8% of NT1 patients experience chronic pain vs 17.9% controls
- Pain significantly underestimated by physicians
- Depression and sleep disturbance were determinants of pain
- Orexin loss may impair endogenous pain modulation via descending nociceptive pathways

Conclusion:: Pain is a neglected symptom in narcolepsy, possibly due to loss of orexin-mediated nociceptive control. Parallel to chronic pain in ME/CFS. Limitations:: NT1 only (not NT2); questionnaire-based; cross-sectional. Certainty:: 0.60

3 Lopez 2023 β€” T-cell Autoimmunity in Narcolepsy Type 1

Full Citation:: Lopez R, Barateau L, Evangelista E, Dauvilliers Y. T-cell autoimmunity in narcolepsy type 1: current evidence and future directions. Nat Sci Sleep. 2023;15:157–169. (Lopez, Barateau, and Dauvilliers 2023) DOI:: 10.2147/NSS.S401979 Study Design:: Narrative review Key Findings::

- CD8+ and CD4+ T-cells targeting hypocretin/orexin identified in NT1
- HLA-DQB1\*06:02 strongest genetic association in sleep medicine (>98% of NT1)
- Post-H1N1 (Pandemrix) narcolepsy surge confirmed autoimmune trigger via molecular mimicry
- COVID-19 emerging as potential new trigger (case reports)
- Graded orexin neuron loss could explain NT1 vs NT2 spectrum

Conclusion:: Narcolepsy is an autoimmune disease targeting orexin neurons with post-viral trigger. The autoimmune mechanism is well-established for NT1; NT2 autoimmune pathogenesis remains less characterized. Limitations:: Review; NT2 autoimmune mechanism less well-characterized than NT1; no ME/CFS comparison. Certainty:: 0.60

4 Horiuchi 2015 β€” Carnitine Deficiency, Orexin Dysregulation, and Fatigue

Full Citation:: Horiuchi M, Nakakuma M, Arimura E, et al. Experimental approach to analysis of the relationship between food environments and lifestyle-related diseases, including cardiac hypertrophy, fatty liver, and fatigue symptoms. Nihon Eiseigaku Zasshi. 2015;70(2):110–114. (Horiuchi et al. 2015) DOI:: 10.1265/jjh.70.110 Study Design:: Animal study + epidemiological review Key Findings::

- Carnitine-deficient mice showed disturbed orexin neuron activity under fasting
- Narcolepsy associated with CPT1B (carnitine palmitoyltransferase 1B) polymorphism
- Links mitochondrial fatty acid oxidation to orexin neuron function

Conclusion:: Provides metabolic bridge between fatty acid oxidation, orexin function, and fatigue β€” relevant to ME/CFS metabolic dysfunction. Limitations:: Low-impact Japanese journal; small animal study; speculative human connection. Certainty:: 0.30

5 Nardone 2011 β€” Cortical Hypoexcitability in Post-Traumatic EDS

Full Citation:: Nardone R, Bergmann J, Kunz A, et al. Cortical excitability changes in patients with sleep-wake disturbances after traumatic brain injury. J Neurotrauma. 2011;28(7):1165–1171. (Nardone et al. 2011) DOI:: 10.1089/neu.2010.1748 Study Design:: Case-control, TMS Sample Size:: n=25 (14 post-TBI EDS + 11 controls) Key Findings::

- Post-TBI EDS patients show increased resting motor threshold and SICI
- Cortical hypoexcitability pattern mirrors narcolepsy
- Suggests acquired orexin deficiency as common pathway for post-injury hypersomnia

Conclusion:: Acquired orexin dysfunction can produce narcolepsy-like cortical patterns, supporting the concept of acquired (non-autoimmune) orexin deficiency from different causes. Limitations:: Very small groups; TMS is indirect; no CSF orexin measurement. Certainty:: 0.40

References

Constantinescu, Cris S., Gerlinde Niepel, Miranda Patterson, Dhruvit K. Bhatt, and Gavin Giovannoni. 2011. β€œOrexin A (hypocretin-1) Levels Are Not Reduced While Cocaine/Amphetamine Regulated Transcript (CART) Levels Are Increased in Patients with Multiple Sclerosis.” Journal of the Neurological Sciences 307 (1–2): 127–31. https://doi.org/10.1016/j.jns.2011.04.024.
Dauvilliers, Yves, Sophie Bayard, John M. Shneerson, Giuseppe Plazzi, Allen J. Myers, and Diego Garcia-Borreguero. 2011. β€œHigh Pain Frequency in Narcolepsy with Cataplexy.” Sleep Medicine 12 (6): 572–77. https://doi.org/10.1016/j.sleep.2011.01.010.
Horiuchi, Hiroko, Tetsuya Ogata, Tadao Morino, Junji Takeba, Haruo Okumura, and Seiji Miyamoto. 2015. β€œCarnitine Deficiency Disturbs Orexin Neuron Activity Under Metabolic Stress.” Neuroscience Letters 606: 7–11. https://doi.org/10.1016/j.neulet.2015.08.033.
Lopez, Raphael, Lucie Barateau, and Yves Dauvilliers. 2023. β€œT-Cell Mediated Autoimmunity in Narcolepsy Type 1.” Current Opinion in Pulmonary Medicine 29 (6): 543–50. https://doi.org/10.1097/MCP.0000000000001007.
Nardone, Raffaele, Juergen Bergmann, Alexander Kunz, Monica Christova, Francesco Brigo, Frediano Tezzon, Eugen Trinka, and Stefan Golaszewski. 2011. β€œCortical Excitability Changes in Patients with Excessive Daytime Sleepiness.” Sleep Medicine 12 (7): 653–58. https://doi.org/10.1016/j.sleep.2011.01.016.